Skip to main content

Advertisement

SpringerLink
Log in

Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland

  • Letter to the Editor
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. NCRI (2009) Summary report 1994–2007. National Cancer Regsitry of Ireland. http://www.ncri.ie/pubs/pubfiles/summary_report_19942007.pdf. Accessed 1 July 2010

  2. Ferlay J, Autier P, Boniol M et al (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581–592

    Article  PubMed  CAS  Google Scholar 

  3. Bang Y-J, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of her2-positive advanced gastric or gastro-oesophageal junction cancer (toga): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697

    Article  PubMed  CAS  Google Scholar 

  4. NCRI (2010) Survival statistics (relative survival). National Cancer Registry Ireland. http://www.ncri.ie/survival/Relsurvival_stomachcancer_19942006.htm. Accessed 1 July 2010

  5. Satoh T, Leon J, Lopez RI et al (2010) Quality of life results from a phase iii trial of trastuzumab plus chemotherapy in first-line her2-positive advanced gastric and GE junction cancer. In: ASCO Gastrointestinal Cancers Symposium Orlando, 2010

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, St James Hospital, Dublin 8, Ireland

    I. M. Collins & K. O’Byrne

  2. Pharmacy Department, St James Hospital, Dublin 8, Ireland

    F. King

Authors
  1. I. M. Collins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. King
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. O’Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. M. Collins.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collins, I.M., King, F. & O’Byrne, K. Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland. Ir J Med Sci 181, 451–452 (2012). https://doi.org/10.1007/s11845-011-0772-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-011-0772-7

Keywords

Search

Navigation